High-mobility group box-1 and its role in angiogenesis
- PMID: 24453275
- DOI: 10.1189/jlb.0713412
High-mobility group box-1 and its role in angiogenesis
Abstract
HMGB1 is an architectural chromatin-binding protein that can be released actively by activated cells or passively by dying cells and can serve as a DAMP molecule to drive the pathogenesis of inflammatory and angiogenic diseases. Through TLR4 and RAGE signaling pathways, HMGB1 could regulate vascular growth in vivo and in vitro through diverse mechanisms, including induction of proangiogenic cytokine release and activation of ECs, macrophages, EPCs, and mesoangioblasts, all of which could contribute to vessel formation. Accordingly, HMGB1 plays a significant role in many angiogenesis-related conditions, such as tumors, PDR, wound-healing, and ischemia-induced angiogenesis. In this review, we focus on the regulatory role of HMGB1 in angiogenesis and recent progress in therapeutic strategies targeting HMGB1.
Keywords: RAGE; TLR4; cytokine; endothelial cells.
Similar articles
-
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Angiogenesis. 2008. PMID: 18264787 Review.
-
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.Oncogene. 2013 Jan 17;32(3):363-74. doi: 10.1038/onc.2012.49. Epub 2012 Mar 5. Oncogene. 2013. PMID: 22391561
-
High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.Am J Pathol. 2012 Jul;181(1):98-110. doi: 10.1016/j.ajpath.2012.03.039. Epub 2012 May 22. Am J Pathol. 2012. PMID: 22634181
-
Inhibition of tumor angiogenesis by HMGB1 A box peptide.Med Hypotheses. 2008;70(2):343-5. doi: 10.1016/j.mehy.2007.05.024. Epub 2007 Jul 13. Med Hypotheses. 2008. PMID: 17630223
-
The role of HMGB1/RAGE in inflammatory cardiomyopathy.Semin Thromb Hemost. 2010 Mar;36(2):185-94. doi: 10.1055/s-0030-1251503. Epub 2010 Apr 22. Semin Thromb Hemost. 2010. PMID: 20414834 Review.
Cited by
-
Exploring Symptom Overlaps: Post-COVID-19 Neurological Syndrome and Post-Concussion Syndrome in Athletes.Biomedicines. 2024 Jul 17;12(7):1587. doi: 10.3390/biomedicines12071587. Biomedicines. 2024. PMID: 39062160 Free PMC article. Review.
-
RAGE plays key role in diabetic retinopathy: a review.Biomed Eng Online. 2023 Dec 19;22(1):128. doi: 10.1186/s12938-023-01194-9. Biomed Eng Online. 2023. PMID: 38115006 Free PMC article. Review.
-
Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia.Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):6-18. doi: 10.1161/ATVBAHA.120.315501. Epub 2021 Nov 23. Arterioscler Thromb Vasc Biol. 2022. PMID: 34809449 Free PMC article.
-
Regulation of Tumor Progression by Programmed Necrosis.Oxid Med Cell Longev. 2018 Jan 31;2018:3537471. doi: 10.1155/2018/3537471. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29636841 Free PMC article. Review.
-
Expression of High-Mobility Group Box 1 Protein (HMGB1) and Toll-Like Receptor 9 (TLR9) in Retinas of Diabetic Rats.Med Sci Monit. 2017 Jun 25;23:3115-3122. doi: 10.12659/msm.902193. Med Sci Monit. 2017. PMID: 28647749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
